Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Current Assets (2020 - 2026)

Invivyd's (IVVD) quarterly Current Assets came in at $182.1 million in Q2 2026, up 207.2% on a YoY basis from $59.3 million in Q2 2025, and down 26.41% quarter-over-quarter from $247.5 million in Q4 2025.

Analysis

Invivyd (IVVD) Current Assets (2020 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Current Assets for 7 consecutive years, with $182.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Assets rose 207.2% year-over-year to $182.1 million; the trailing twelve-month figure through Jun 2026 stood at $182.1 million (up 207.2% YoY), and the FY2025 full-year result was $247.5 million, up 145.79% from the prior year.
  • Current Assets declined to $182.1 million in Q2 2026 per IVVD's latest filing, from $247.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $554.3 million in Q1 2022 and bottomed at $59.3 million in Q2 2025.
  • Historically, Current Assets has averaged $252.5 million across 5 years, with a median of $224.9 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Current Assets sank 65.74% in 2025, then surged 207.2% in 2026.
  • Over 5 years, Current Assets stood at $376.9 million in 2022, then plunged by 40.34% to $224.9 million in 2023, then slumped by 55.23% to $100.7 million in 2024, then surged by 145.79% to $247.5 million in 2025, then fell by 26.41% to $182.1 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $182.1 million, $247.5 million, and $109.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 8.07 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 4.62 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 7.31 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.63 Bn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 182.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 182.11 Mn
Dec 31, 2025 247.47 Mn
Sep 30, 2025 109.77 Mn
Jun 30, 2025 59.28 Mn
Mar 31, 2025 75.83 Mn
Dec 31, 2024 100.68 Mn
Sep 30, 2024 151.10 Mn
Jun 30, 2024 173.01 Mn
Mar 31, 2024 209.88 Mn
Dec 31, 2023 224.88 Mn
Sep 30, 2023 270.10 Mn
Jun 30, 2023 309.99 Mn
Mar 31, 2023 344.62 Mn
Dec 31, 2022 376.92 Mn
Sep 30, 2022 421.60 Mn
Jun 30, 2022 481.36 Mn
Mar 31, 2022 554.30 Mn
Dec 31, 2021 616.71 Mn
Sep 30, 2021 680.16 Mn
Jun 30, 2021 396.06 Mn